SAN DIEGO, CA — In a small Phase 2 study presented at the 53 rd American Society of Hematology’s Annual Meeting and Exposition, once-daily prasugrel 5mg for 30 days showed some promise of decreasing ...
While dual antiplatelet therapy (DAPT) has long been the standard of care for the management of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), there is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results